A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with distinct genetic mutations compared to either therapy alone or sequentially, according to results ...
Sep 9, 2024
0
0
In a new study published in Circulation: Cardiovascular Quality and Outcomes, researchers at Yale School of Medicine say an artificial intelligence (AI) tool can use electrocardiographic (ECG) images to define the risk of ...
Sep 9, 2024
0
0
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes ...
Sep 9, 2024
0
0
Treatment with BAY 2927088 led to rapid, substantial, and durable responses in patients with heavily pretreated HER2-mutant non-small cell lung cancer (NSCLC), according to research presented at the International Association ...
Sep 9, 2024
0
0
The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients with HER2 mutation-positive non-small cell lung cancer, meeting the primary endpoint of the Beamion ...
Sep 9, 2024
0
0
The combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response rate compared to osimertinib alone, according to research presented at the International Association for the Study ...
Sep 9, 2024
0
0
One July evening, Allison Rosenthal, D.O., received a flurry of texts with exclamations like, "Yo, my doctor friend is famous!"
Sep 9, 2024
0
0
Skin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researchers said on Monday.
Sep 9, 2024
0
0
Cellular immunotherapy, a leading form of cancer treatment, enlists the "warriors" of our immune system, our T-cells, in the war on cancer. During preparations for the treatment, doctors take a sample of T-cells from the ...
Sep 9, 2024
0
48
A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.
Sep 9, 2024
0
1
